Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis
Clinical trial NCT01148810 · TERMINATED
Trial details
- NCT number
- NCT01148810
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-15
- Primary completion
- 2012-06-13
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.